ClinicalTrials.gg
WithdrawnNCT03348111PERIFLOWUpdated Aug 26, 2020

Establishing a New Protocol for Early Mucositis and Peri-implantitis Treatment Using an Air-polishing Device

An interventional study of Air-polishing device in Peri-Implantitis and Mucositis, sponsored by University Hospital, Toulouse. Withdrawn at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-08-26.

Sponsored by University Hospital, Toulouse · Not applicable, Interventional, and Treatment

Why this study was withdrawn
No participant enrolled
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Considering the frequent occurence of peri-implantitis and mucositis, a multiple of treatment alternatives have been proposed including non-surgical and surgical procedures. However, it seems that the most effective treatment remains prevention of these diseases.

The aim of this study is to emphasize on mucositis and peri-implantitis prevention using an air abrasion device the Air-Flow Master Piezon® with erythritol and chlorhexidine powder in order to eliminate and / or disorganize the biofilm responsible for peri-implant mucosa inflammation.

Read the detailed description

Peri-implant infections (mucositis and peri-implantitis) depict an increasing focus in dental practice and implantology. mean prevalence of mucositis is of 43% and periimplantitis of 22%. Consequences for the implant without successful treatment range from local reversible inflammation (mucositis) to implant loss (periimplantitis). These lead to functional, social and esthetic prejudices for patients. The main factor for establishment of peri-implant infections is the formation and maturation of the bacterial biofilm. Peri-implantitis and mucositis treatment require the removal of the bacterial biofilm and the disinfection of the implant surface. Because of special surface conditions and structures, it is more difficult to remove bacterial biofilms from implant surfaces than teeth. the key to controlling the inflammation due to the bacterial biofilm is to prevent its installation and progression. The procedure tested in this study is an air abrasion device, the Air-Flow Master Piezon® with erythritol and chlorhexidine powders on implants presenting clinical and radiographic signs of mucositis and peri-implantitis along with renewal of local oral hygiene instructions in order to reduce the inflammation locally by disorganizing and eliminating the biofilm. Follow-up of the patients will be held every 2 months for 6 months by scoring the bleeding on probing, the plaque index and measuring clinical attachment level in order to compare it with the initial measure. At 6 month an X-ray will also enable to compare bone level and mineralization. This initial study will help establish a standardized protocol for peri-implant infection management.

02

Conditions studied

  • Peri-Implantitis
  • Mucositis

Keywords

  • Mucositis
  • Peri-Implantitis
  • Air-Flow Master Piezon®
03

In context

Peri-Implantitis

322 studies on the registry are indexed under Peri-Implantitis; 88 are open to participants now.

Browse Peri-Implantitis studies →

Lead sponsor

University Hospital, Toulouse is the lead sponsor of 807 studies on the registry; 209 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • adult patients,
  • possessing one or more implants prosthetically engaged with local peri-implant mucosa inflammation assessed by bleeding on probing
  • affiliated with a social security scheme

Exclusion criteria

Exclusion Criteria:

  • patients with implant mobility or implants associated with vestibular cellulitis
  • not available patients for the follow-up visits
  • patients with known allergy to erythritol and/or Chlorhexidine powder
  • patients with chronic bronchitis
  • patients with asthma
  • patients with endocarditis
  • patients with contagious disease
  • patients with immunodeficiency
  • patients under radiotherapy and/or chemotherapy and/or antibiotics
  • not mastery of plaque control on the part of the patient (after education)
  • subjects under legal protection
  • pregnant or breastfeeding women
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Air-polishing device

    Air polishing of the implant surface and/or elimination of the intrapocket biofilm using the air abrasion device Air-Flow Master Piezon®

    Device: Air-polishing device

Interventions

  • DeviceAir-polishing device

    Air abrasion using the Air-Flow Master Piezon® with erythritol and Chlorhexidine powders on implants presenting clinical and radiographic signs of mucositis and peri-implantitis along with renewal of local oral hygiene instructions in order to reduce the inflammation locally

    Also known as: Air-Flow Master Piezon®

06

What researchers measure

Primary outcomes

  1. Change from baseline peri-implant inflammation at 6 months

    bleeding on probing (binary criteria : yes/no)

    Time frame: 6 months

  2. Change from baseline peri-implant inflammation at 4 months

    bleeding on probing (binary criteria : yes/no)

    Time frame: 4 months

  3. Change from baseline peri-implant inflammation at 2 months

    bleeding on probing (binary criteria : yes/no)

    Time frame: 2 months

Secondary outcomes

  1. stability of the bone level

    bone level assessed by X-ray

    Time frame: 6 months

  2. clinical attachment gain

    The measurement of the probing depth and of the eventual recession (compared to Baseline) allows to assess the clinical attachment gain

    Time frame: 2 months

  3. clinical attachment gain

    The measurement of the probing depth and of the eventual recession (compared to Baseline) allows to assess the clinical attachment gain

    Time frame: 4 months

  4. clinical attachment gain

    The measurement of the probing depth and of the eventual recession (compared to Baseline) allows to assess the clinical attachment gain

    Time frame: 6 months

  5. Quality of life with Oral Health Assessment Tool (OHAT)

    The Oral Health Assessment Tool (OHAT) was a component of the Best Practice Oral Health Model for Australian Residential Care study. The OHAT provided institutional carers with a simple, eight category screening tool to assess residents' oral health, including those with dementia

    Time frame: 6 months

  6. Quality of life with the Geriatric Oral Health Assessment Index (GOHAI)

    The Geriatric Oral Health Assessment Index (GOHAI) is a self-reported measure designed to assess the oral health problems of older adults

    Time frame: 6 months

07

Study locations

1 site
  • University Hospital Toulouse (Faculty of Dental Surgery)
    Toulouse, 31059, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 26, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03348111
Responsible party
Sponsor
First posted
Nov 20, 2017
Start date
Jun 2019 (estimated)
Primary completion
Jun 2021 (estimated)
Completion
Jun 2021 (estimated)
Last update
Aug 26, 2020

Study contacts

Sara Laurencin, MD
principal investigator · University Hospital of Toulouse

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion